Asia Executives To Watch: New FDA China Director Named Amid ICH Push
Executive Summary
The US FDA has sent its country director from Peru to build a closer relationship with the China FDA, while the CFDA's own medical device center is also going through a series of leadership changes.
You may also be interested in...
Asia Executives To Watch: FDA Names New India Director
FDA has named a new head for India while Roche has appointed a new VP for its anti-infectives and specialty care business unit in China. Personnel changes have also been effected at Bayer, Cook Medical, and the biopharma startup Kira Therapeutics.
FDA Tip-Toes In China To Push Data Integrity, Harmonization
US FDA warning letters to Chinese firms may be on the increase, but ties with the Chinese regulator appear to be growing. US FDA showcases how to get more done in fast-changing China via aligning with China FDA's aspiration for quality and international harmonization.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.